- Home
- ALTG vs FHTX Comparison
ALTG vs FHTX Comparison
Compare ALTG & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- FHTX
- Stock Information
- Founded
- ALTG 1984
- FHTX 2015
- Country
- ALTG United States
- FHTX United States
- Employees
- ALTG N/A
- FHTX N/A
- Industry
- ALTG Industrial Machinery/Components
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- ALTG Industrials
- FHTX Health Care
- Exchange
- ALTG Nasdaq
- FHTX Nasdaq
- Market Cap
- ALTG 247.6M
- FHTX 278.1M
- IPO Year
- ALTG N/A
- FHTX 2020
- Fundamental
- Price
- ALTG $8.04
- FHTX $4.98
- Analyst Decision
- ALTG Buy
- FHTX Strong Buy
- Analyst Count
- ALTG 3
- FHTX 8
- Target Price
- ALTG $11.67
- FHTX $12.63
- AVG Volume (30 Days)
- ALTG 221.6K
- FHTX 106.1K
- Earning Date
- ALTG 08-07-2025
- FHTX 08-05-2025
- Dividend Yield
- ALTG 2.84%
- FHTX N/A
- EPS Growth
- ALTG N/A
- FHTX N/A
- EPS
- ALTG N/A
- FHTX N/A
- Revenue
- ALTG $1,851,100,000.00
- FHTX $24,173,000.00
- Revenue This Year
- ALTG $1.89
- FHTX $33.60
- Revenue Next Year
- ALTG $3.09
- FHTX $5.87
- P/E Ratio
- ALTG N/A
- FHTX N/A
- Revenue Growth
- ALTG N/A
- FHTX N/A
- 52 Week Low
- ALTG $3.54
- FHTX $2.95
- 52 Week High
- ALTG $8.99
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- ALTG 55.97
- FHTX 44.97
- Support Level
- ALTG $7.39
- FHTX $4.48
- Resistance Level
- ALTG $8.48
- FHTX $5.23
- Average True Range (ATR)
- ALTG 0.44
- FHTX 0.39
- MACD
- ALTG 0.01
- FHTX -0.07
- Stochastic Oscillator
- ALTG 57.74
- FHTX 23.65
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.